Medplus Health Services valuation

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Price multiples — at each FY-end close
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
33.85×————
3.45×————
0.94×————
19.17×————
Enterprise multiples
0.91×————
10.96×————
21.57×————
Yield
3.0%————
5.2%————
Reference — adjusted share basis
₹595.00————
₹17.58₹18.30₹12.52₹5.45₹4.15
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MEDPLUS₹595.00

Medplus Health Services Ltd.

· Consumer Services
₹ CrorePeersAPOLLOHOSPMANYAVARMSTCLTDNESCOJUSTDIALJSLLQUESSIXIGOMcap ₹7,143 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E————33.85
P/B————3.45
P/Sales————0.94
Price to Free Cash Flow————19.17
Enterprise Multiples
EV/Sales————0.91
EV/EBITDA————10.96
EV/EBIT————21.57
Yield
Earnings Yield %————2.95
FCF Yield %————5.22
Reference — adjusted share basis
Price (FY-end close, adj.)————595.00
EPS (adj.)4.155.4512.5218.3017.58
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.